20 results
PRE 14A
PTPI
Petros Pharmaceuticals, Inc.
30 Sep 22
Preliminary proxy
4:45pm
and Management
Management and Corporate Governance
Certain Relationships and Related Person Transactions
Executive Officer and Director Compensation … Governance
The Board of Directors
Our Board of Directors currently consists of five members (each, a “Director”): John D. Shulman, Joshua N
424B3
vh1dlyk08ps6 bc61
14 Jan 22
Prospectus supplement
5:18pm
DEF 14A
i1b1qdi6p
22 Nov 21
Definitive proxy
4:37pm
10-K
wse1d582 r33z6
31 Mar 21
Annual report
4:30pm
8-K
EX-3.2
ye5cb
2 Dec 20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
9:14am
8-K
EX-10.1
agpz fj86wwhhu7p6
2 Dec 20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
9:14am
424B3
ukv1l8xdledl
2 Nov 20
Prospectus supplement
12:00am
S-4/A
t612682z nla4b7
30 Sep 20
Registration of securities issued in business combination transactions (amended)
9:21am
S-4
05egjvcs5hhg dyq
24 Jul 20
Registration of securities issued in business combination transactions
12:00am
- Prev
- 1
- Next